XARELTO® LAWSUIT CONSULTATIONS THAT ARE

What is Xarelto® (Rivaroxaban)?

Xarelto® (also known as Rivaroxaban) is an anti-coagulant drug (blood thinner) that helps reduce the risk of strokes and blood clots. By thinning the blood, Xarelto® helps prevent the formation of blood clots in people with:

• Atrial Fibrillation (nonvalvular)

Nonvalvular atrial fibrillation is a condition characterized by an irregular heartbeat that is not caused by a heart valve dysfunction.

• Deep Vein Thrombosis (DVT)

Deep vein thrombosis, or DVT, is a blood clot that forms in a vein deep in the body. It is the result of blood becoming thicker and clumping together.

• Pulmonary Embolism (PE)

Pulmonary Embolism is a condition that occurs when a blood clot that formed in the body (typically deep vein thrombosis, or DVT) breaks loose and travels to the lungs, causing one or more pulmonary arteries in the lungs to become blocked. Often doctors refer to this occurence as venous thromboembolism (VE).

• Post Knee Replacement or Hip Replacement Surgery

Doctors often prescribe Xarelto® (Rivaroxaban) to patients that just underwent knee replacement or hip replacement surgery to prevent the risk of forming blood clots in the legs or lungs.

• Risk of Forming Blood Clots While Hospitalized

Hospitalized patients are often prescribed Xarelto® (Rivaroxaban) as a preventative measure to lessen the risk of forming blood clots (venous thrombosis) during their hospital stay.

Who Invented Xarelto®? And Why Do Doctors Prescribe Xarelto® Over The More Tested Warfarin®?

Xarelto® (Rivaroxaban) was developed by the pharmaceutical drug company Bayer, but sold to Johnson & Johnson's subsidiary Janssen Pharmaceutica for sale in the U.S. It was invented to be part of a new class of drugs called Novel Oral Anticoagulants (NOACs), commonly referred to as the "next generation of blood thinning drugs" designed to replace the long-used Warfarin® (also known as, Coumadin).

The big selling point of Xarleto® has been that it was marketed as an anticoagulant that does not require patients to be routinely monitored by their doctor. In other words, patients could just pop the pills on day 1 and not need to return to the doctor every week, or every month, to make sure the dose they were receiving was correct. Unlike Warfarin® (it's biggest competitor), Xarelto® was marketed to appear "safe to take" without continued doctor supervision.

But we now know, this was a tragic mistake...

(continued, keep scrolling...)

What's The Big Problem With Xarelto®?

The big problem with Xarelto® is that it's marketed as a blood thinner that does not require routine testing (ie. supervision) from a doctor.

But is it really safe enough to be on without routine supervision?

New research, suggests that it isn't. Not only that, but this latest research shows that Xarelto® is statistically higher in risk for gastrointestinal bleeding and higher for discontinuation due to adverse events compared to its competitor Warfarin®.

According to a systematic review, Xarelto® may show increased internal bleeding risks for those over the age of 75, compared to Warfarin® under routine supervision from a doctor.

What Legal Grounds Do Internal Bleeding Victims Have For Pursuing A Xarelto® Lawsuit?

As a potential internal bleeding victim of Xarelto®, you may be wondering what legal grounds victims may have for pursing a Xarelto® lawsuit.

We can discuss this in more detail during your free phone consultation, but put simply, there are at minimum six (6) potential allegations that give internal bleeding victims grounds for filing a Xarelto® lawsuit. Those six are...

• Failure To Mention That A Blood Test Could Have Estimated Your Risk Of A Major Bleed

A simple blood test could have easily estimated the risk of a major internal bleeding event, and continued testing could have ensured proper dosing. However, the makers of Xarelto® never stated this and even marketed the drug as being safe for use without routine blood tests.

• Failure To Warn of Uncontrollable Internal Bleeding Side Effects

Janssen Pharmaceutica marketed Xarelto® as a blood thinner that does not require routine supervision and testing from a doctor. Recent studies have shown this may be tragic and harmful advice to both the doctors who prescribe it, and the patients who take it.

• Failure To Warn of Irreversible Internal Bleeding (No Known Interventions)

In the event that internal bleeding does occur while on Xarelto®, there is no known intervention that can reverse (or stop) the bleeding. They may have failed to warn doctors and patients adequately about this very important consideration and risk.

• Failure To Properly Update Product Warnings

When new research and statistical evidence is made available, it is the legal obligation of pharmaceutical companies to update their product labels to warn of newly discovered risks in a timely manner.

• Releasing A Drug With Known Defective Design

Many believe an anticoagulant such as Xarelto® with no known method for reversing internal bleeding in the event that it occurs, is a defective drug that carries excessive risk, especially considering there are options (ie. Warfarin®) that do have known interventions for reversing internal bleeding events.

• Failure To Execute A Xarelto® Recall Admist New, Alarming Information

There may be ample argument that Janssen Pharmaceutica should have recalled Xarelto® as soon as it was made aware of the new, alarming research.

As you can see, victims currently have significant reason to consider filing a Xarelto® lawsuit.

Individual Xarelto® Lawsuits and Xarelto® Class Action Lawsuits

Victims of an internal bleeding injury caused by Xarelto must know the differences and advantages of filing an individual Xarelto® lawsuit compared to participating in a Xarelto® class action lawsuit. Our managing attorney, Andrew Bederman, will clearly explain the many reasons why an individually filed Xarelto® lawsuit is typically more advantageous for seriously injured victims than participating in a class action suit against Xarelto Janssen Pharmaceutica.

There are critical facts you need to be aware of when considering the choice between an individual or class action law suit, and our goal is to educate you on these crucial considerations so you can make the best decision for you and your family.

Additionally, we will discuss with you the probability of obtaining a Xarelto® settlement, and how the manufacturer of Pradaxa® (another anticoagulant drug) recently agreed to pay $650 million in settlements to victims who filed lawsuits claiming injury.

Continue reading to see who may be eligible...

(continued, keep scrolling...)

Who Is Eligible To Receive A Free Xarelto® Lawsuit Consultation With Our Managing Attorney?

For a limited time, we are offering victims personal, one-on-one Xarelto® lawsuit consultations with Greenberg & Bederman's managing attorney, Andy Bederman.

The legal consultation is 100% free. There are zero risks and absolutely no obligation to ever pay us or work with us. It's your risk-free chance to talk to an experienced pharmaceutical drug lawyer who has practiced law for over 35 years.

But our free Xarelto® lawsuit consultation is only available to victims who have experienced any of the following adverse effects while on Xarelto®:

FREE XARELTO® LAWSUIT CONSULTATIONS FOR VICTIMS WHO EXPERIENCED:

• Internal Bleeding (any)
• Gastrointestinal (GI) Bleeding (stomach/intestinal)
• Hemorrhagic Stroke
• Brain Bleeding
• Rectal Bleeding
• Major Bleeding (internal or external)
• Hemorrhages (internal or external hemorrhaging)
• Deep Vein Thrombosis (DVT, blood clots)
• Pulmonary Embolism (PE)
• Spinal Blood Clots
• Fatal Bleeding (Death due to uncontrollable bleeding)

So if you or a loved one was a victim of any of the above adverse events due to Xarelto®, please contact Greenberg & Bederman today to get a free Xarelto® lawsuit consultation.

Fill out the contact form below, or call (800) 800-1144 (touch number to call) right now to get started.

Talk To Greenberg & Bederman If You Want "No Pressure" Legal Advice That is Easy to Understand!

When you are ready to discuss your potential Xarelto® lawsuit with a law firm, you want a lawyer that can clearly explain...

1. What your eligibility is for pursuing financial compensation with a Xarelto® lawsuit
2. What you could stand to receive in terms of money damages (ask about "Pradaxa"!)
3. What is involved in the process of filing a lawsuit
4. How soon you may be able to receive a settlement or award
5. ...and much more.

You will also be able to ask any questions you may have, too.

Please don't wait to contact us. There is a limited time window we will be offering free consultations with our managing attorney (and accepting cases).

We look forward to having a conversation with you! Talk to you soon!